PRATI, GIAN MARIA
 Distribuzione geografica
Continente #
EU - Europa 2.517
NA - Nord America 1.847
AS - Asia 1.817
SA - Sud America 157
AF - Africa 61
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.426
Nazione #
US - Stati Uniti d'America 1.764
GB - Regno Unito 954
CN - Cina 579
SG - Singapore 476
DE - Germania 431
IT - Italia 324
RU - Federazione Russa 177
SE - Svezia 155
VN - Vietnam 146
HK - Hong Kong 138
BD - Bangladesh 125
BR - Brasile 105
NL - Olanda 101
IN - India 99
FR - Francia 96
UA - Ucraina 91
TR - Turchia 73
CA - Canada 62
IE - Irlanda 62
KR - Corea 57
EU - Europa 44
FI - Finlandia 42
CI - Costa d'Avorio 23
CO - Colombia 21
ID - Indonesia 21
JP - Giappone 20
AU - Australia 16
DK - Danimarca 16
CL - Cile 14
BE - Belgio 13
AR - Argentina 10
PL - Polonia 10
PH - Filippine 9
PK - Pakistan 9
UG - Uganda 9
UZ - Uzbekistan 9
EG - Egitto 8
IR - Iran 8
TW - Taiwan 8
ZA - Sudafrica 8
CH - Svizzera 7
ES - Italia 7
IL - Israele 7
IQ - Iraq 7
MX - Messico 7
BG - Bulgaria 5
MY - Malesia 5
SA - Arabia Saudita 5
AT - Austria 4
CR - Costa Rica 4
EC - Ecuador 3
EE - Estonia 3
JO - Giordania 3
KE - Kenya 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
IS - Islanda 2
JM - Giamaica 2
LV - Lettonia 2
MA - Marocco 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SM - San Marino 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BS - Bahamas 1
CG - Congo 1
DO - Repubblica Dominicana 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
JE - Jersey 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MQ - Martinica 1
NG - Nigeria 1
RE - Reunion 1
TM - Turkmenistan 1
WS - Samoa 1
Totale 6.464
Città #
Southend 881
Singapore 244
Ashburn 188
Chandler 168
Beijing 138
Hong Kong 117
Frankfurt am Main 85
Seattle 83
Milan 77
Santa Clara 77
San Jose 75
Jacksonville 73
Princeton 68
Dearborn 60
Dublin 60
Mountain View 51
Ann Arbor 47
Ho Chi Minh City 46
Los Angeles 46
Dallas 44
Hanoi 43
Wilmington 43
Redmond 41
Toronto 38
New York 36
Council Bluffs 32
Bengaluru 31
Serra 31
Boardman 30
Des Moines 30
Nanjing 28
Lauterbourg 25
Moscow 25
Woodbridge 25
Andover 24
Sakarya 24
Shanghai 24
Abidjan 23
Buffalo 23
Columbus 21
Guangzhou 21
Bogotá 19
Saint Petersburg 19
Jinan 17
The Dalles 17
Nanchang 16
Munich 15
Cangzhou 14
Fairfield 14
Somerville 14
Houston 13
Phoenix 13
Shenyang 13
Tianjin 13
Piscataway 12
Brussels 11
Da Nang 11
Hangzhou 11
Helsinki 11
San Diego 11
Tokyo 11
Turin 11
Jakarta 10
Jiaxing 10
Berlin 9
Kampala 9
Seoul 9
London 8
Rome 8
Zhengzhou 8
Cambridge 7
Changsha 7
Grafing 7
Hebei 7
Mumbai 7
San Antonio 7
Sydney 7
Chicago 6
Eitensheim 6
Fuzhou 6
Haiphong 6
Hefei 6
Ottawa 6
Redwood City 6
Stockholm 6
São Paulo 6
Taipei 6
Belo Horizonte 5
Bitonto 5
Bologna 5
Istanbul 5
Johannesburg 5
Kent 5
Naples 5
Nuremberg 5
Orem 5
Scranton 5
Shenzhen 5
Warsaw 5
Washington 5
Totale 3.777
Nome #
Prevalence of psychiatric disorders during PEG – Interferon and Ribavirin therapy in patients with chronic hepatitis HCV-correlated 401
The dica endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists: An international study 281
L'IMPATTO DEL POLIMORFISMO GENETICO IL 28B SUL TRATTAMENTO ANTIVIRALE CON INTERFERONE PEGHILATO E RIBAVIRINA IN PAZIENTI CON EPATITE CRONICA C GENOTIPO 4 278
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegykated interferon-α2A in chronic hepatitis C : an in vitro and in vivo study 274
The natural history of compensated cirrhosis due to hepatitis C virus : A 17-year cohort study of 214 patients 270
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C 252
Serum expression of lectin reactive alphafetoprotein, des-gamma-carboxy prothrombin, Golgi protein-73 antigen and antibody, for the diagnosis of hepatocellular carcinoma 249
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy 243
Genotype dependent pattern of peginterferon alfa-2b/ribavirin treatment failure in hepatiti sC virus infected patients with cirrhosis : a single center study of 471 naive patients 232
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 226
Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients 225
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-alpha 2a in chronic hepatitis C : an in vitro and in vivo study 224
Successful treatment of hepatocellular carcinoma (HCC) with transchateter arterial embolization (TAE) with microspheres (embosphere) 221
Predictors of psychopathological outcome during peg-interferon and ribavirin therapy in patients with chronic HCV-correlated hepatitis 221
Genotype dependent pattern of Peginterferon alfa-2B/Ribavirin treatment failure in hepatitis C virus infected patients with cirrhosis : a single centre study of 471 naïve patients 215
The influence of liver fibrosis on the outcome of pegylated interferon and ribavirin anti-hac therapy : a sub-analysis of the mist study 209
The diagnostic accuracy of fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with an SVR 208
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype 207
Hepatitis C virus genotypes and patterns of peginterferon alfa-2b/ribavirin treatment failure in patients with cirrhosis : a single center study of 471 naïve patients 205
Randomized Study of Peginterferon-alpha2a Plus Ribavirin vs Peginterferon-alpha2b Plus Ribavirin in Chronic Hepatitis C 203
Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis 201
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study 197
Interferoni pegilati nel trattamento dei pazienti con epatite cronica HCV : esperienze a confronti 182
Successful treatment of hepatocellular carcinoma (hcc) with transchateter arterial embolization (tae) with microspheres (embosphere) 182
Single-incision laparoscopic surgery (SILS) for the treatment of ileocolonic Crohn’s disease: a propensity score–matched analysis 175
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C 167
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study 164
Surgical treatment of colonic Crohn’s disease: a national snapshot study 159
Prospective evaluation of staging systems for hepatocellular carcinoma detected during surveillance of cirrhotic patients 154
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study 149
The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3 : Should we utilize more? 146
Totale 6.720
Categoria #
all - tutte 18.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022399 36 17 7 13 16 27 37 32 54 46 36 78
2022/2023537 60 78 56 56 45 114 9 15 65 7 28 4
2023/2024359 7 29 14 24 115 36 11 20 22 13 29 39
2024/2025845 39 84 7 111 82 29 22 58 48 95 79 191
2025/20261.718 217 93 158 103 156 99 224 85 117 141 187 138
2026/202736 36 0 0 0 0 0 0 0 0 0 0 0
Totale 6.720